[HTML][HTML] The antigenic anatomy of SARS-CoV-2 receptor binding domain
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
The antigenic anatomy of SARS-CoV-2 receptor binding domain
W Dejnirattisai, D Zhou, HM Ginn… - Cell, 2021 - mahidol.elsevierpure.com
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
The antigenic anatomy of SARS-CoV-2 receptor binding domain
W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn… - Cell, 2021 - pure.lib.cgu.edu.tw
摘要Antibodies are crucial to immune protection against SARS-CoV-2, with some in
emergency use as therapeutics. Here, we identify 377 human monoclonal antibodies …
emergency use as therapeutics. Here, we identify 377 human monoclonal antibodies …
[HTML][HTML] The antigenic anatomy of SARS-CoV-2 receptor binding domain
W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn… - Cell, 2021 - Elsevier
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
The antigenic anatomy of SARS-CoV-2 receptor binding domain.
W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn… - 2021 - cabidigitallibrary.org
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
The antigenic anatomy of SARS-CoV-2 receptor binding domain
W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn… - Cell, 2021 - pubmed.ncbi.nlm.nih.gov
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
The antigenic anatomy of SARS-CoV-2 receptor binding domain
W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn… - paper.sciencenet.cn
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here we identify 377 human monoclonal antibodies (mAbs) …
The antigenic anatomy of SARS-CoV-2 receptor binding domain
W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn… - Cell, 2021 - kar.kent.ac.uk
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here we identify 377 human monoclonal antibodies (mAbs) …
The antigenic anatomy of SARS-CoV-2 receptor binding domain
W Dejnirattisai, JB Case, NM Kafai, AL Bailey… - 2021 - digitalcommons.wustl.edu
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
[HTML][HTML] The antigenic anatomy of SARS-CoV-2 receptor binding domain
W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn… - Cell, 2021 - cell.com
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …